The U.S. healthcare conglomerate said it would wind down sales of the product, which makes up about 0.5% of its U.S. consumer health business, in the coming months, but that retailers will continue to sell existing inventory.
from Moneycontrol Latest News https://ift.tt/3g7xOYc
0 Comments